Pharmagreen welcomes Tyrell Crosby

Marc Zerbola Challande
minute read

Pharmagreen Biotech (OTCQB: PHBI), a company specializing in the advanced science of tissue culture, announced in late November that Tyrell Crosby, a professional NFL player, join the company as an honorary sports ambassador. Tyrell Crosby is an American football offensive tackle currently a free agent. He played college football at Oregon and professionally for the Detroit Lions. Tyrell will spread the word about the benefits of NutraMax, such as how the product helps him with his wellness and the importance of nutraceuticals for all athletes serious about their performance and everyday body and mind balance. This addition comes after the arrival of Ethan Styles as VP of product research and development.

About Pharmagreen / Sector Expansion

Pharmagreen Biotech is a Nevada-based company poised for strong growth. Pharmagreen builds a vertically integrated cannabis business in California. Pharmagreen’s process, “Chibafreen,” is a proprietary tissue culture system ensuring that all plants are free from disease and pests while maintaining uniformity from generation to generation. The company can provide the cultivation and manufacture of the highest quality craft cannabis products. The company acquired in January Long Valley Farms to cultivate and harvest scarce plant species using new technology to store the live plant species for life using tissue cultures with patented cold storage technology. The place is vegan and non-spray certified by the county of Mendocino.

Combined with cannabis, Pharmagreen expands nutraceutical solutions. The sector is already tremendous (worth USD $396B) and is expected to grow at a CAGR of 5.2% until 2030. Nutraceuticals notably help to cope with metabolic disorders, and it keeps growing worldwide. According to the IDF, more than 30% of the US population is estimated to have metabolic syndrome. In the sports area, it concerns the relationship between nutrients, diet, and genetic expression. Pharmagreen created its first line of genomic supplements, which will be available soon through Shopify, Amazon, other third-party online outlets, and the company’s pending online store.

The company’s first supply of NutraMax Genomic Supplement enteric capsules is currently being produced at a Current Good Manufacturing Practice (CGMP) certified production facility in the US. All the organic plants and fungi biomaterials are being tested and certified for their contaminant-free content, and a certificate of analysis is matched with the suppliers.

Tyrell Crosby will support Pharmagreen’s nutraceutical products, the NutraMax Genomic Supplement product line. To spread awareness, he will attend gatherings, trade shows, and other scheduled events selected by the company and explain why he approves NutraMax on various social media. His expertise will be significant because, thanks to his experience,  Crosby knows well the need for mind and body wellness in dealing with injuries, rehabilitation, and recovery.

“After having the opportunity to sample the NutraMax Genomic Supplement and making it part of my everyday wellness program, I knew Pharmagreen was onto something great. Nutraceutical products are very important supplements for all athletes serious about their performance and everyday body and mind balance. I get this with NutraMax, and I am excited to be involved with Pharmagreen to help the company grow its business.”
Tyrell Crosby.

Regarding cannabis, the industry was valued at USD $17.8B in 2021 and is expected to grow at a CAGR of 25.3% from 2022 to 2030. Cannabis receives worldwide acceptance from governments and legislation. For example, in the USA, 21 states and Washington, DC have already legalized cannabis, and medical marijuana is legal in 38 states and Washington, DC. Another positive news about the sector? President Biden signed a marijuana research bill on December 2, which makes it a historic first for federal cannabis reform. The bill cleared the House in July and the Senate last month, and a White House spokesperson confirmed to Marijuana Moment that the president intended to sign it. On Friday, he did just that. The president remains opposed to federal cannabis legalization. Still, he campaigned on several more modest marijuana reforms, including promoting research, decriminalization, and rescheduling cannabis under the Controlled Substances Act (CSA).

Share Movement

Despite the imminent revenue stream, the company’s market cap decreased to bottom at $1.91M. PHBI trades around $0.005. The company’s stock price had a 52-week high of $0.027 and a 52-week low of $0.001. More than ever, the company is strongly undervalued, considering Pharmagreen Biotech strengthened its board with the arrival of Tyrell Colby and market opportunities thanks to the ease in legislation. The stock volume had a higher trading activity on December 3. The stock price’s average volume is worth 278k, but in the last trading session, this data reached 322k. What could attract investors is the official launch of nutraceutical products, which will announce the beginning of revenue.

“Our partnership with Tyrell Crosby, a professional athlete dedicated to his own health and wellness as well as to others’ wellbeing, is a great opportunity to have our product represented by a conscientious and knowledgeable brand ambassador. Hearing Tyrell talk about how NutraMax helps him with his wellness has been a validating experience for our team as we develop nutrigenomic products designed to bring balance and health to people’s lives.  We are very excited to be launching this product with Tyrell’s help and endorsement.”
Peter Wojcik, CEO of Pharmagreen

Bottom Line

Pharmagreen Biotech (OTCQB: PHBI) added Tyrell Crosby as its honorary sports ambassador, and the launch of the NutraMax Genomic Supplement product line is imminent. The meager valuation is due because the company doesn’t have significant revenue, but it is just a question of time before the company generates some. This is why we are optimistic about the company.